NEWS

Vesalio Announces the Completion of Enrollment in Its FDA IDE Clinical S...

Nashville, TN May 11, 2022 --(  PR.com  )-- Vesalio is excited to announce the completion of patient enrollment for the CLEAR(1) FDA IDE study utilizing the NeVa™ thrombectomy platform. This is an important milestone for Vesalio to complete for entering the U.S. neurovascular market to treat patients suffering from acute ischemic stroke (AIS).

Management of ophthalmic artery pseudoaneurysm

MicroVention Announces First Patient Enrolled in the STRAIT Study with t...

Aliso Viejo, CA – April 20, 2022 – MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced the successful completion of its first enrollment in a multi-center, prospective EU observational study called STRAIT, to evaluate the Safety and Performance of the BOBBY Balloon Guide Catheter for Endovascular Treatment of Acute Ischemic Stroke.

A WEB nightmare situation to face

Evolve: Early Experience (Symposium)

Day 1 - Back together again in Miami

Day 2 - The practice of INR advances for us all!

Access #LINNCAmericas streaming now!

Ángel Chamorro interview - The CHOICE Randomized Clinical Trial

ACom Aneurysm Recurrence treated with Flow diverter